2024 SV Therapeutics Impact & ESG Report
Read More
Alpheus Medical Announces Positive Phase 1/2 Trial Results for the Treatment of Recurrent High-Grade Gliomas
Data Presented at the American College of Chest Physicians Correlates Airway Remodeling with Positive Clinical Outcomes Utilizing the RejuvenAir® System
SpectraWAVE Announces $50M Series B Financing to Drive Commercial Expansion and Product Additions to the HyperVue™ Imaging System
Pulse Biosciences, Inc. Appoints Paul LaViolette to Its Board of Directors - Paul LaViolette to serve as Co-Chairman alongside Robert W. Duggan, adding 40 years of medical technology development, operating and leadership expertise
Spineology® Announces $25 Million Equity Financing – Funding to aid in acceleration of commercial growth, clinical education programs, and product development enhancements for highly-differentiated OptiMesh® implant portfolio –
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
Endotronix Receives FDA Premarket Approval of the Cordella™ PA Sensor System for the Treatment of Heart Failure
Merck signs $3bn deal for Kate Bingham-backed eye disease biotech
Read More
SV Health Investors-created EyeBio to be acquired by MSD for up to $3 billion
Nanopath Receives $4 Million in Grants from National Institutes of Health and National Science Foundation
QurAlis to Present Data That Show its Splice-Switching ASOs Restore UNC13A Function in ALS and Frontotemporal Dementia
SV investment has resulted in the approval of 24 novel therapeutics
SV Health Investors bolsters senior biotech team - appoints Nikola Trbovic as Managing Partner and hires Jamil Beg as Partner
Hightop Health adds industry veteran to Board of Directors - Seasoned CEO and McLean Hospital Board Chair joins Hightop’s executive leadership
Merck to Acquire Caraway Therapeutics, Inc.
EyeBio Announces Expansion of Series A to $130 Million, Advances Development of Restoret for Retinal Diseases
SV Health Investors partners with HIT Executives Dave Dyell and Marc Hirshfield to Lead Recapitalization of Innovative Consulting Group
SV News
14 October 2020Portfolio NewsHealthify Partners with Altruista Health to Help Payors Address SDoH
1 October 2020Portfolio NewsNordic acquires Tasman Global
17 September 2020Portfolio NewsSchweiger Dermatology Group Acquires the New York Dermatology Practices of Lillian Graf, M.D. and Leopold Laufer, M.D.
14 September 2020Portfolio NewsJet Health, Inc. Acquires Carrington Hospice Care, Inc.
8 September 2020Portfolio NewsBardy Diagnostics® Announces Appointment of Kevin Hykes as President and Chief Executive Officer
19 August 2020Portfolio NewsCentauri Health Solutions Announces Acquisition of HCFS- 12 August 2020Portfolio NewsCentauri Health Solutions Ranks No. 448 on the 2020 Inc. 5000 List of America’s Fastest-Growing Private Companies
- 4 August 2020Portfolio NewsCentauri Health Solutions Adds New Analytics Capabilities with Acquisition of AppRev
- 21 July 2020Portfolio NewsHealthify Partners with Ride Health to Provide Non-Medical Transportation Services to People in Need
1 July 2020Portfolio NewsEvidation Raises $45 Million Series D, Hires CCO To Accelerate Commercial Momentum and Expand Into Virtual Health- 4 June 2020Portfolio NewsCollaboration aims to develop predictive algorithm for symptoms of COVID-19 by monitoring first responders
- 27 May 2020Portfolio NewsCOVID-19's 'unprecedented stress' on social services drives demand for innovative SDOH programs
